Walgreens Burn Gel
NDC Package 0363-2020-25

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Walgreens Burn (lidocaine hydrochloride) gel is adults and children 2 years and over: apply to affected area not more than 3 to 4 times dailychildren under 2 years: ask a doctor. This formulation utilizes a gel delivery system. Marketed by Walgreens, this product is identified by NDC 0363-2020 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
0363-2020-25
Package Description
1 TUBE in 1 CARTON / 74 g in 1 TUBE
Product Code
0363-2020
11-Digit Billing Format
00363202025
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Walgreens Burn
Non-Proprietary Name
Lidocaine Hydrochloride
Substance Name
Lidocaine Hydrochloride
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
LIDOCAINE HYDROCHLORIDE 4 g/100g
Pharmacologic Class
Usage Information
Adults and children 2 years and over: apply to affected area not more than 3 to 4 times dailychildren under 2 years: ask a doctor

Regulatory & Marketing

Labeler Name
Walgreens
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-16-2021
End Marketing Date
11-30-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0363-2020-25 identifies a specific commercial package of 1 tube in 1 carton / 74 g in 1 tube of Walgreens Burn, a human over the counter drug labeled by Walgreens. This gel is formulated for topical use and contains lidocaine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Walgreens on July 16, 2021.

How is this Walgreens product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00363202025. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0363-2020-25
11-Digit CMS (5-4-2)
00363-2020-25

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.